Medicine and food homologous active composition for treating vitiligo by multi-target point intervention

Abstract

The invention relates to a medicine and food homologous active composition for treating vitiligo by multi-target point intervention. The medicine and food homologous active composition is prepared from the following components in parts by weight: 90 to 300 parts of sargassum fusiforme extract, 90 to 300 parts of fructus gardeniae extract, 90 to 300 parts of lemon extract, 90 to 300 parts of onionextract, 90 to 300 parts of porphyra extract, 90 to 300 parts of concha ostreae extract, 90 to 300 parts of herba portulacae extract, 90 to 300 parts of herba menthae extract, 90 to 300 parts of almond extract, 90 to 300 parts of green tea extract and 90 to 300 parts of broad bean extract. Clinical trial proves that the active composition disclosed by the invention has high cure rate and remarkable cure effects for vitiligo patients.

Description

technical field [0001] The invention relates to the technical field of targeted treatment of vitiligo, in particular to a pharmaceutically active composition for multi-target intervention treatment of vitiligo. Background technique [0002] Vitiligo is an acquired chronic skin depigmentation disease, the main feature is the selective destruction of melanocytes. The clinical manifestations are depigmented spots with clear boundaries and no scales attached, mostly appearing around the mouth, around the eyes, fingers, dorsum of feet, genitals, hair, etc. Rapidly spread all over the body, and some patients have symptoms of graying hair. The onset of Vitiligo does not distinguish between age, sex and race, and very few patients are born with Vitiligo skin lesions. Recent epidemiological studies have reported that about 0.5 to 1% of people worldwide suffer from vitiligo, and this proportion has gradually increased in recent years. Vitiligo affects the appearance of the face, wh...

AI Technical Summary

Problems solved by technology

5. The theory of trace element deficiency, the level of copper or ceruloplasmin in the blood and skin of patients with vitiligo is reduced, resulting in a decrease in tyrosinase activity, thus affecting the metabolism of melanin

There are also many deficiencies in the experimental research on the treatment of vitiligo with traditional Chinese medicine, namely: ① There are almost no researches on the pharmacokinetics and toxicology of traditional Chinese medicine.

② There are few reports on the active ingredients of traditional Chinese medicine, and there are few studies on the exact mechanism of traditional Chinese medicine, such as the exact signaling pathway of Chinese medicine to promote melanocyte proliferation and melanin synthesis

③ There are few horizontal comparative experiments among effective drugs

④ There are few experimental studies on external use of traditional Chinese medicine

[0005] The most important thing is that so far there is no report of a vitiligo drug with a high cure rate or a clear and effective cure

Images